Race/Gender-Specific Densitometry Database Warning Endorsed By Panel
This article was originally published in The Gray Sheet
Executive Summary
Gender and ethnicity-specific databases used with bone densitometry/sonometry devices to assess fracture risk should include cautionary language that their relevance has not undergone sufficient clinical evaluation, FDA's Radiological Devices Panel agreed at a May 17 meeting in Rockville, Maryland.
You may also be interested in...
Bone Sonometry PMAs Need Supporting Data From Caucasian Females
Patient databases used in support of premarket approval of bone densitometry/sonometry devices in assessing fracture risk should consist of Caucasian females 20-29, according to an FDA final guidance.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.